Drawing upon the 15th Annual Chips to Hits®, 7th Annual Biomarkers, and 7th annual Molecular Diagnostics meetings, IBC developed the Discovery2Diagnostics Conference & Exhibition to reflect recent changes in these industries and to capture opportunities presented by the fast-paced developments in technologies and research throughout the discovery to diagnostics spectrum.
The scope of this meeting includes more RNAi related research and development as it effects sequencing and detection technologies, biomarkers and molecular diagnostics, recent work to deliver point-of-care (or near POC) molecular diagnostics and sessions with panel discussions on related regulatory and reimbursement issues. The challenges experienced by those involved in the Discovery2Diagnostics spectrum and the enabling breakthroughs that bridge the gap between biomarkers and molecular diagnostics in the R&D setting and the clinic will also be explored.
The scope of this meeting includes more RNAi related research and development as it effects sequencing and detection technologies, biomarkers and molecular diagnostics, recent work to deliver point-of-care (or near POC) molecular diagnostics and sessions with panel discussions on related regulatory and reimbursement issues. The challenges experienced by those involved in the Discovery2Diagnostics spectrum and the enabling breakthroughs that bridge the gap between biomarkers and molecular diagnostics in the R&D setting and the clinic will also be explored.
